In a decades-long effort, researchers have discovered how to tweak the molecular pathways that turn heart muscle motors up or ...
US biotech Cytokinetics (Nasdaq: CYTK) has secured the first global approval for its cardiac myosin inhibitor aficamten, ...
When it comes to Cobenfy’s indication, the FDA objected to the suggestion in the ad that the drug has efficacy in ...
He called his routine a "monk's life" for a decade, training through holidays like Chinese New Year. As a gym owner, he ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback